Cynthia Barrett

Statistics

Publications

Citations

323

H-Index

Active since

2002

Affiliations

Millennium Engineering and Integration (United States)(Current)

Cynthia Barrett is an author at Millennium Engineering and Integration (United States) specializing in medicinal chemistry, drug discovery, and enzyme inhibition.

Publications per year

2002–2014

Publications

Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit

Christopher Blackburn, Kenneth M. Gigstad, Paul Hales et al. · Biochemical Journal · 2010 · 146 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +14

Discovery of a Potent and Orally Bioavailable Benzolactam-Derived Inhibitor of Polo-Like Kinase 1 (MLN0905)

Matthew O. Duffey, Tricia J. Vos, Ruth Adams et al. · Journal of Medicinal Chemistry · 2011 · 56 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Potent Histone Deacetylase Inhibitors Derived from 4-(Aminomethyl)-<i>N</i>-hydroxybenzamide with High Selectivity for the HDAC6 Isoform

Christopher Blackburn, Cynthia Barrett, Janice E. Chin et al. · Journal of Medicinal Chemistry · 2013 · 42 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Optimization of a series of dipeptides with a P3 threonine residue as non-covalent inhibitors of the chymotrypsin-like activity of the human 20S proteasome

Christopher Blackburn, Cynthia Barrett, Jonathan L. Blank et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 40 citations

Life Sciences, Biochemistry, Molecular Biology +15

pH Dependence of inhibitors targeting the occluding loop of cathepsin B

Brian E. Cathers, Cynthia Barrett, James T. Palmer et al. · Bioorganic Chemistry · 2002 · 22 citations

Life Sciences, Biochemistry, Medicinal Chemistry +14

1–5 of 6